Pharmacological interventions for non-ulcer dyspepsia (Q24234257)

2

0 references

Jonathan J Deeks

3

0 references

Brendan Delaney

4

0 references

Michael Innes

5

0 references

David Forman

Cochrane Database of Systematic Reviews

6

0 references

publication date

16 February 2011

0 references

published in

0 references

cites work

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Helicobacter pyloriInfection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Symptom improvement from prokinetic therapy corresponds to improved quality of life in patients with severe dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Clinical presentation and personality factors are predictors of the response to treatment in patients with functional dyspepsia; a randomized, double-blind placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

The multi-crossover model for classifying patients as responders to a given treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Dyspepsia in primary care: acid suppression as effective as prokinetic therapy. A randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Gastric emptying and gastrointestinal symptoms in patients with atrophic gastritis and the effects of domperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (non-ulcer) dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Gastric and autonomic responses to stress in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Endoscopic studies of dyspepsia in a general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

What are the real problems for patients with functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Dyspepsia in England and Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Long term acid suppressing treatment in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Helicobacter pylori infection in non-ulcer dyspeptic and ulcer patients. Determinants and consequences in 'real life'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

Cimetidine in the management of symptomatic patients with duodenitis: a double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Electrogastrography in patients with gastroparesis and effect of long-term cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effect of cisapride on gastric emptying in dyspeptic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Sucralfate versus placebo in treatment of non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Organic and functional disorders in 2000 gastroenterology outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Do young patients with dyspepsia need investigation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

The effect of a single rectal dose of cisapride on delayed gastric emptying

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

A controlled trial of cimetidine for the treatment of nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effect of treatment with cisapride alone or in combination with domperidone on gastric emptying and gastrointestinal symptoms in dyspeptic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Efficacy of cisapride therapy in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Domperidone in the Treatment of Dyspepsia: A Double-Blind Placebo-Controlled Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Double-blind evaluation of domperidone in acute vomiting and dyspeptic disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Pirenzepine in non-ulcer dyspepsia: a double-blind multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Social and economic effects of non-ulcer dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Non-ulcer dyspepsia in Nigerians clinical and therapeutic results.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Famotidine in the treatment of gastritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Sucralfate in gastritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cimetidine responders in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Campylobacter pylori and non-ulcer dyspepsia. 1. The final results of a double-blind multicentre trial for treatment with pirenzepine in Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Campylobacter pylori--a role in non-ulcer dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cisapride in functional dyspepsia: a double-blind, placebo-controlled randomized trial in general practice patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cisapride in chronic dyspepsia: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Pathophysiology and treatment of functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Psychosocial factors and their role in symptomatic gastroesophageal reflux disease and functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021

Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001960.PUB4

7 January 2021